11.01.17
SWITZERLAND: Johnson & Johnson Consumer Inc. presented new scientific posters at the 2017 European Academy of Dermatology and Venerology (EADV) Annual Meeting in Geneva, Switzerland in September. It was the first time the research was shown in Europe, including new findings in the areas of skin microbiome, light therapy for acne, retinol for anti-aging and treatment of androgenetic alopecia.
“Our research presented at this year’s meeting is an excellent representation of core areas of interest for the global dermatology community,” explained Menas Kizoulis, associate director, global scientific engagement at Johnson & Johnson Consumer Inc. “Two of the posters showcase new insights in the emerging area of skin microbiome, including linkages between reduced microbial diversity and severity of atopic dermatitis, and assessments on changes in skin microbiome as children approach puberty.”
According to Kizoulis, J&J is also sharing data on the safety and efficacy of a full-face, at-home light therapy mask for acne, as well as new understandings about the mechanism of action for minoxidil foam hair treatment.
“Our research presented at this year’s meeting is an excellent representation of core areas of interest for the global dermatology community,” explained Menas Kizoulis, associate director, global scientific engagement at Johnson & Johnson Consumer Inc. “Two of the posters showcase new insights in the emerging area of skin microbiome, including linkages between reduced microbial diversity and severity of atopic dermatitis, and assessments on changes in skin microbiome as children approach puberty.”
According to Kizoulis, J&J is also sharing data on the safety and efficacy of a full-face, at-home light therapy mask for acne, as well as new understandings about the mechanism of action for minoxidil foam hair treatment.